Benign prostatic hyperplasia Enucleation HoLEP Laser ThuLEP

Minimally Invasive Surgical Treatment Benign prostatic hyperplasia Systematic review

Kirurgia  Työterveyshuolto  Urologia  Yleislääketiede

Urtica Dioica Benign Prostatic Hyperplasia Meta-Analysis

Plasmakinetic resection technology benign prostatic hyperplasia meta-analysis

5-alpha Reductase Inhibitors Humans Lower Urinary Tract Symptoms/pathology Male Muscarinic Antagonists Phosphodiesterase 5 Inhibitors Prostatic Hyperplasia/complications/*drug therapy/pathology *Randomized Controlled Trials as Topic

Adult Aged Austria Diagnosis Differential Humans Image-Guided Biopsy Magnetic Resonance Imaging Interventional Male Middle Aged Prostate Prostatic Hyperplasia/pathology Prostatic Neoplasms Retrospective Studies Sensitivity and Specificity

Humans Laser Therapy Length of Stay Male Postoperative Complications Prostatic Hyperplasia Quality of Life Randomized Controlled Trials as Topic Time Factors *Transurethral Resection of Prostate Treatment Outcome Urinary Catheterization

Adrenergic alpha-Antagonists Cholinergic Antagonists Drug Therapy Combination Humans Male Prostatic Hyperplasia/*drug therapy Aur Bph Co Er I-pss International Prostate Symptom Score Luts Pvr Qmax Rct Wmd acute urinary retention adrenergic alpha-antagonists benign prostatic hyperplasia cholinergic antagonists combination therapy combined modality therapy extended release lower urinary tract symptoms maximal urinary flow rate meta-analysis post-void residual urine volume prostatic hyperplasia randomized clinical trial weighted mean difference